Cargando…

Tuberculosis Relapse in the Epididymis After the Completion of Nine Months of Anti-Tuberculosis Chemotherapy in a Patient with Poorly Controlled Diabetes Mellitus

The standard six-month tuberculosis (TB) treatment comprises an intensive phase lasting two months, followed by a continuation phase lasting four months. Meanwhile, the nine-month regimen, which has a prolonged continuation phase, is indicated for patients with complicated diabetes mellitus (DM) bec...

Descripción completa

Detalles Bibliográficos
Autores principales: Ichikawa, Chikako, Tanaka, Sho, Takubo, Masahiro, Kushimoto, Masaru, Ikeda, Jin, Ogawa, Katsuhiko, Tsujino, Ichiro, Suzuki, Yutaka, Abe, Masanori, Ishihara, Hisamitsu, Fujishiro, Midori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164866/
https://www.ncbi.nlm.nih.gov/pubmed/34079268
http://dx.doi.org/10.2147/TCRM.S310463
_version_ 1783701207268720640
author Ichikawa, Chikako
Tanaka, Sho
Takubo, Masahiro
Kushimoto, Masaru
Ikeda, Jin
Ogawa, Katsuhiko
Tsujino, Ichiro
Suzuki, Yutaka
Abe, Masanori
Ishihara, Hisamitsu
Fujishiro, Midori
author_facet Ichikawa, Chikako
Tanaka, Sho
Takubo, Masahiro
Kushimoto, Masaru
Ikeda, Jin
Ogawa, Katsuhiko
Tsujino, Ichiro
Suzuki, Yutaka
Abe, Masanori
Ishihara, Hisamitsu
Fujishiro, Midori
author_sort Ichikawa, Chikako
collection PubMed
description The standard six-month tuberculosis (TB) treatment comprises an intensive phase lasting two months, followed by a continuation phase lasting four months. Meanwhile, the nine-month regimen, which has a prolonged continuation phase, is indicated for patients with complicated diabetes mellitus (DM) because of their poor response to treatment. A 61-year-old Japanese man with poorly controlled DM for five years presented with bilateral scrotal swelling noticed two weeks ago. He had a history of pleuritis, pericarditis, and peritonitis two years ago. These symptoms led to the diagnosis of culture-negative extrapulmonary TB. He received the nine-month chemotherapy regimen (isoniazid, rifampin, pyrazinamide, and ethambutol for two months, followed by isoniazid and rifampin for seven months), and his symptoms significantly improved. The swollen scrotum was accompanied by mild tenderness and pus discharge from a fistula. Imaging study revealed bilaterally diffusely enlarged epididymis. However, the acid-fast bacilli smear and culture and polymerase chain reaction using urine and pus discharge tested negative. Bilateral epididymectomy was performed. Although the acid-fast bacilli smear was negative, the pathology demonstrated granuloma formation and acid-fast bacilli tissue culture confirmed multi-drug resistant Mycobacterium tuberculosis. The optimal treatment regimen and duration for extrapulmonary TB with unknown drug susceptibility are debatable. The nine-month regimen can be insufficient in some cases. Thus, detailed follow-up is essential, and TB relapse should be thoroughly monitored.
format Online
Article
Text
id pubmed-8164866
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-81648662021-06-01 Tuberculosis Relapse in the Epididymis After the Completion of Nine Months of Anti-Tuberculosis Chemotherapy in a Patient with Poorly Controlled Diabetes Mellitus Ichikawa, Chikako Tanaka, Sho Takubo, Masahiro Kushimoto, Masaru Ikeda, Jin Ogawa, Katsuhiko Tsujino, Ichiro Suzuki, Yutaka Abe, Masanori Ishihara, Hisamitsu Fujishiro, Midori Ther Clin Risk Manag Case Report The standard six-month tuberculosis (TB) treatment comprises an intensive phase lasting two months, followed by a continuation phase lasting four months. Meanwhile, the nine-month regimen, which has a prolonged continuation phase, is indicated for patients with complicated diabetes mellitus (DM) because of their poor response to treatment. A 61-year-old Japanese man with poorly controlled DM for five years presented with bilateral scrotal swelling noticed two weeks ago. He had a history of pleuritis, pericarditis, and peritonitis two years ago. These symptoms led to the diagnosis of culture-negative extrapulmonary TB. He received the nine-month chemotherapy regimen (isoniazid, rifampin, pyrazinamide, and ethambutol for two months, followed by isoniazid and rifampin for seven months), and his symptoms significantly improved. The swollen scrotum was accompanied by mild tenderness and pus discharge from a fistula. Imaging study revealed bilaterally diffusely enlarged epididymis. However, the acid-fast bacilli smear and culture and polymerase chain reaction using urine and pus discharge tested negative. Bilateral epididymectomy was performed. Although the acid-fast bacilli smear was negative, the pathology demonstrated granuloma formation and acid-fast bacilli tissue culture confirmed multi-drug resistant Mycobacterium tuberculosis. The optimal treatment regimen and duration for extrapulmonary TB with unknown drug susceptibility are debatable. The nine-month regimen can be insufficient in some cases. Thus, detailed follow-up is essential, and TB relapse should be thoroughly monitored. Dove 2021-05-25 /pmc/articles/PMC8164866/ /pubmed/34079268 http://dx.doi.org/10.2147/TCRM.S310463 Text en © 2021 Ichikawa et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Case Report
Ichikawa, Chikako
Tanaka, Sho
Takubo, Masahiro
Kushimoto, Masaru
Ikeda, Jin
Ogawa, Katsuhiko
Tsujino, Ichiro
Suzuki, Yutaka
Abe, Masanori
Ishihara, Hisamitsu
Fujishiro, Midori
Tuberculosis Relapse in the Epididymis After the Completion of Nine Months of Anti-Tuberculosis Chemotherapy in a Patient with Poorly Controlled Diabetes Mellitus
title Tuberculosis Relapse in the Epididymis After the Completion of Nine Months of Anti-Tuberculosis Chemotherapy in a Patient with Poorly Controlled Diabetes Mellitus
title_full Tuberculosis Relapse in the Epididymis After the Completion of Nine Months of Anti-Tuberculosis Chemotherapy in a Patient with Poorly Controlled Diabetes Mellitus
title_fullStr Tuberculosis Relapse in the Epididymis After the Completion of Nine Months of Anti-Tuberculosis Chemotherapy in a Patient with Poorly Controlled Diabetes Mellitus
title_full_unstemmed Tuberculosis Relapse in the Epididymis After the Completion of Nine Months of Anti-Tuberculosis Chemotherapy in a Patient with Poorly Controlled Diabetes Mellitus
title_short Tuberculosis Relapse in the Epididymis After the Completion of Nine Months of Anti-Tuberculosis Chemotherapy in a Patient with Poorly Controlled Diabetes Mellitus
title_sort tuberculosis relapse in the epididymis after the completion of nine months of anti-tuberculosis chemotherapy in a patient with poorly controlled diabetes mellitus
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164866/
https://www.ncbi.nlm.nih.gov/pubmed/34079268
http://dx.doi.org/10.2147/TCRM.S310463
work_keys_str_mv AT ichikawachikako tuberculosisrelapseintheepididymisafterthecompletionofninemonthsofantituberculosischemotherapyinapatientwithpoorlycontrolleddiabetesmellitus
AT tanakasho tuberculosisrelapseintheepididymisafterthecompletionofninemonthsofantituberculosischemotherapyinapatientwithpoorlycontrolleddiabetesmellitus
AT takubomasahiro tuberculosisrelapseintheepididymisafterthecompletionofninemonthsofantituberculosischemotherapyinapatientwithpoorlycontrolleddiabetesmellitus
AT kushimotomasaru tuberculosisrelapseintheepididymisafterthecompletionofninemonthsofantituberculosischemotherapyinapatientwithpoorlycontrolleddiabetesmellitus
AT ikedajin tuberculosisrelapseintheepididymisafterthecompletionofninemonthsofantituberculosischemotherapyinapatientwithpoorlycontrolleddiabetesmellitus
AT ogawakatsuhiko tuberculosisrelapseintheepididymisafterthecompletionofninemonthsofantituberculosischemotherapyinapatientwithpoorlycontrolleddiabetesmellitus
AT tsujinoichiro tuberculosisrelapseintheepididymisafterthecompletionofninemonthsofantituberculosischemotherapyinapatientwithpoorlycontrolleddiabetesmellitus
AT suzukiyutaka tuberculosisrelapseintheepididymisafterthecompletionofninemonthsofantituberculosischemotherapyinapatientwithpoorlycontrolleddiabetesmellitus
AT abemasanori tuberculosisrelapseintheepididymisafterthecompletionofninemonthsofantituberculosischemotherapyinapatientwithpoorlycontrolleddiabetesmellitus
AT ishiharahisamitsu tuberculosisrelapseintheepididymisafterthecompletionofninemonthsofantituberculosischemotherapyinapatientwithpoorlycontrolleddiabetesmellitus
AT fujishiromidori tuberculosisrelapseintheepididymisafterthecompletionofninemonthsofantituberculosischemotherapyinapatientwithpoorlycontrolleddiabetesmellitus